Evidence map›Paper›PMID 33846078›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2021

Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records.

Krista L Lentine, Paolo R Salvalaggio, Yasar Caliskan, Ngan N Lam, Mara McAdams-DeMarco, David Axelrod, Dorry L Segev, Larissa Myaskovsky, Mary Amanda Dew, Heather Bruschwein and 5 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 3 countries.

Krista L LentineSaint Louis Transplant Center, St. Louis, Missouri, USA. Electronic address: krista.lentine@health.slu.edu.
Paolo R SalvalaggioHospital Israelita Albert Einstein, Sao Paulo, Brazil.
Yasar CaliskanSaint Louis Transplant Center, St. Louis, Missouri, USA.
Ngan N LamUniversity of Calgary, Calgary, Alberta, Canada.
Mara McAdams-DeMarcoJohns Hopkins School of Medicine, Baltimore, Maryland, USA.
David AxelrodUniversity of Iowa, Iowa City, Iowa, USA.
Dorry L SegevJohns Hopkins School of Medicine, Baltimore, Maryland, USA.
Larissa MyaskovskyUniversity of New Mexico, Albuquerque, New Mexico, USA.
Mary Amanda DewUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Heather BruschweinUniversity of Virginia School of Medicine, Charlottesville, Virginia, USA.
Deborah J LevineUniversity of Texas, San Antonio, Texas, USA.
Stuart SweetWashington University, St. Louis, Missouri, USA.
Gregory P HessDrexel University, Philadelphia, Pennsylvania, USA.
Bertram L KasiskeHennepin County Medical Center, Minneapolis, Minnesota, USA.
Mark A SchnitzlerSaint Louis Transplant Center, St. Louis, Missouri, USA.
Johns Hopkins Medicine · USDrexel University · USHennepin County Medical Center · USHospital Israelita Albert Einstein · BRThe University of Texas at San Antonio · USUniversity of Calgary · CAUniversity of Iowa · USUniversity of New Mexico · USUniversity of Pittsburgh · USUniversity of Virginia · USWashington University in St. Louis · US

Funding

Developing personalized immunosuppression for older kidney transplant recipientsR01DK120518 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MCADAMS DEMARCO, MARA A. · 2019 to 2022
$2.7M
NIDDK NIH HHS R01 DK120518
6 · The paper itself

Abstract

backgroundPrescription opioid and benzodiazepine use have been associated with morbidity and mortality among some groups of solid organ transplant recipients, but implications for outcomes among lung transplant patients are not well described.

methodsWe conducted a retrospective cohort study using linked national transplant registry and pharmaceutical records to characterize the associations between benzodiazepine and opioid prescription fills in the years before and after lung transplant (2006-2017), with risk-adjusted posttransplant survival (adjusted hazard ratio,

resultsAmong 11,568 recipients, 33.7% filled an opioid prescription, and 25.8% filled a benzodiazepine prescription before transplant. Compared to patients without prescriptions, those who filled both short- and long-acting benzodiazepine prescriptions before transplant had 2-fold higher mortality in the first year posttransplant (aHR,

conclusionsBenzodiazepine prescription fills before and after lung transplant, and opioid fills after transplant, are independently associated with posttransplant mortality. Review of benzodiazepine and opioid use history is relevant to risk-stratifying patients before and after lung transplant.

Indexed as

RegistriesTransplant RecipientsAdolescentAdultAnalgesics, OpioidDrug PrescriptionsFemaleFollow-Up StudiesGlobal HealthHumansIncidenceLung TransplantationMaleMiddle AgedOpioid-Related DisordersPostoperative PainAnalgesics, Opioidbenzodiazepineslung transplantmortalityopioidspharmacy fills

Identifiers

PMID33846078
PMCPMC8169588
OpenAlexW3130522979

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.